Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas.
OBJECTIVE
Carcinoembryonic antigen (CEA) is known to be elevated in nearly all solid malignancies. The prognostic role of CEA in gastric cancers however, is still controversial. We evaluated preoperative serum CEA levels and CEA expression from the resected tumor tissues to determine whether they have prognostic significance in gastric cancer patients.


METHODS
Medical records of 810 patients who underwent surgery for gastric adenocarcinoma from June, 1998 to February, 2002 in Kyungpook National University Hospital were reviewed. Serum CEA level was evaluated by radioimmunoassay preoperatively, and the cut-off level for positivity was 7.0 ng/ml. Labeled streptavidin-biotin peroxidase method was used to determine CEA expression from the gastric cancer tissues.


RESULTS
Serum and tissue CEA were positive in 9.3% and 91.1% of the patients, respectively. They had no correlation with each other. The positivity rate of serum CEA had positive correlation with invasion depth (p<0.001), lymph node metastasis (p<0.001), distant metastasis (p=0.006), and final stage (p<0.001). Well differentiated tumors showed higher serum CEA positivity (p=0.002). Patients with positive serum CEA had higher recurrence rate (p<0.001). Multivariate analysis showed significantly lower survival rate in patients with preoperative CEA levels over 7 ng/ml than those with lower levels (48.0% vs. 80.7%; p<0.001). The positivity rates of tissue CEA were higher in advanced cancers (p=0.033) and in more advanced stages (p=0.029). Tissue CEA positivity showed no correlation with recurrence or survival.


CONCLUSIONS
Preoperative serum CEA level had correlation with disease progression and survival in gastric cancer patients, and proved to be an independent prognostic factor. Tissue CEA expression in gastric cancers had no prognostic information.
Park
Seong-Hoon
SH
Department of Surgery, Kyungpook National University Hospital, Daegu, Korea.
Ku
Ki-Beom
KB
Chung
Ho-Young
HY
Yu
Wansik
W
J Surg Res. 1989 Jul;47(1):81-6
2739403
Jpn J Clin Oncol. 1999 Nov;29(11):550-5
10678558
Transplantation. 1963 Apr;1:174-80
14010646
Cancer Res. 1977 Jul;37(7 Pt 1):2267-74
67888
Oncology. 1995 Nov-Dec;52(6):483-6
7478435
Virchows Arch A Pathol Anat Histopathol. 1986;409(5):715-24
3092465
Scand J Clin Lab Invest Suppl. 1995;221:5-14
7652491
Cancer Res. 1989 Sep 1;49(17):4852-8
2474375
Cancer. 1994 Jun 1;73(11):2703-8
8194009
Nihon Geka Gakkai Zasshi. 1983 Apr;84(4):328-35
6371486
Surg Oncol. 1996 Jun;5(3):133-9
8908719
Am J Gastroenterol. 1996 Jan;91(1):49-53
8561143
Ann Intern Med. 1981 Mar;94(3):407-9
7224393
Hum Pathol. 1974 Mar;5(2):139-47
4811605
Cancer. 1976 Jan;37(1):62-81
1247968
JAMA. 1976 May 3;235(18):1975-9
56468
Jpn J Cancer Res. 1990 Jan;81(1):58-62
2108947
Cancer. 1988 Aug 1;62(3):534-40
2455589
J Am Coll Surg. 1998 Jul;187(1):64-8
9660027
Proc Natl Acad Sci U S A. 1969 Sep;64(1):161-7
5262998
Gan. 1984 Mar;75(3):230-6
6373475
Gastric Cancer. 1998 Dec;1(1):10-24
11957040